Leap Therapeutics Reports Second Quarter 2022 Financial Results

Go back to Leap Therapeutics Reports Second Quarter 2022 Financial Results
(NASDAQ: LPTX) Delayed: 2.06 --0 (-0%)
Previous Close $2.06    52 Week High
Open $2.06    52 Week Low
Day High $2.06    P/E N/A 
Day Low $2.06    EPS
Volume